Cargando…

ICER's timelines for assessments extended due to COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140250/
https://www.ncbi.nlm.nih.gov/pubmed/32288506
http://dx.doi.org/10.1007/s40274-020-6689-5
_version_ 1783518952482144256
collection PubMed
description
format Online
Article
Text
id pubmed-7140250
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71402502020-04-08 ICER's timelines for assessments extended due to COVID-19 PharmacoEcon Outcomes News News Item Springer International Publishing 2020-04-04 2020 /pmc/articles/PMC7140250/ /pubmed/32288506 http://dx.doi.org/10.1007/s40274-020-6689-5 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
ICER's timelines for assessments extended due to COVID-19
title ICER's timelines for assessments extended due to COVID-19
title_full ICER's timelines for assessments extended due to COVID-19
title_fullStr ICER's timelines for assessments extended due to COVID-19
title_full_unstemmed ICER's timelines for assessments extended due to COVID-19
title_short ICER's timelines for assessments extended due to COVID-19
title_sort icer's timelines for assessments extended due to covid-19
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140250/
https://www.ncbi.nlm.nih.gov/pubmed/32288506
http://dx.doi.org/10.1007/s40274-020-6689-5